Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
02/2006
02/23/2006US20060040277 Nucleic sequences encoding an AT2 receptor-interacting protein (ATIP) and their applications
02/23/2006US20060040276 Molecular recognition at surfaces derivatized with self-assembled monolayers
02/23/2006US20060040275 C-shaped probe
02/23/2006US20060040272 Composition comprising library of double stranded nucleic acids
02/23/2006US20060040271 Processes for detecting or quantifying more than one nucleic acid in a library
02/23/2006US20060040270 Processes for detecting or quantifying more than one nucleic acid in library
02/23/2006US20060040268 Nucleotide sequences specific to Francisella tularensis and methods for the detection of Francisella tularensis
02/23/2006US20060040265 Regulation of novel human asparagine-hydroxylases
02/23/2006US20060040262 Novel compositions and methods in cancer
02/23/2006US20060040261 Primers for isothermal amplification of hepatitis C virus
02/23/2006US20060039925 Mutants of streptococcal toxin a and methods of use
02/23/2006US20060039922 Streptococcal heat shock proteins of the Hsp60 family
02/23/2006US20060039919 an E7 peptide sequence of human papillomavirus type 16, a translocation peptide and a peptide within a carboxyl terminal fragments, used for inhibiting urogenital cancers induced or caused by HPV type 16
02/23/2006US20060039905 Galectin 11
02/23/2006US20060039884 Baldness related gene and the polypeptide encoded thereby , and uses
02/23/2006CA2577660A1 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues
02/23/2006CA2577597A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor
02/23/2006CA2577036A1 Small interfering rna molecules against ribonucleotide reductase and uses thereof
02/23/2006CA2576904A1 Method for rapid identification of microorganisms
02/23/2006CA2576886A1 Tie complex binding proteins
02/23/2006CA2575368A1 Cloning and expression of recombinant adhesive protein mefp-1 of the blue mussel, mytilus edulis
02/23/2006CA2573998A1 Cleavable solid phases for isolating nucleic acids
02/23/2006CA2573989A1 Methods of using cleavable solid phases for isolating nucleic acids
02/23/2006CA2573905A1 Compositions and methods for releasing nucleic acids from solid phase binding materials
02/22/2006EP1627919A1 An infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
02/22/2006EP1627081A2 Use of jag2 expression in diagnosis of plasma cell disorders
02/22/2006EP1627061A2 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)
02/22/2006EP1627050A2 Variant humicola grisea cbh1.1
02/22/2006EP1626988A2 Intron fusion proteins, and methods of identifying and using same
02/22/2006EP1626979A2 Genetically modified yeast species and fermentation processes using genetically modified yeast
02/22/2006EP1626978A2 Polymerase-based protocols for the introductions of deletions and insertions
02/22/2006EP1626733A2 Prokaryotic collagen-like proteins and uses thereof
02/22/2006EP1626650A2 Methods and probes for identifying vulnerable plaque
02/22/2006EP1463750A4 Plant cyclopropane fatty acid synthase genes, proteins and uses thereof
02/22/2006EP1453961B1 Stabilisation of double-stranded nucleic acids using proteins
02/22/2006EP1434882A4 Aptamers containing sequences of nucleic acids or nucleic acid analogues bound homologously, or in novel complexes
02/22/2006EP1212464B1 Diagnostics and therapeutics for osteoporosis
02/22/2006EP1109564B1 Method for removal of hiv and other viruses from blood
02/22/2006EP0957929B1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes
02/22/2006EP0787206B1 USE OF NEURITE LOCALIZED mRNAs FOR MEDICAL DIAGNOSIS AND THERAPEUTICS
02/22/2006EP0656060B1 Androgen regulation with dna sequences of rat probasin gene
02/22/2006EP0549615B1 Sugar modified oligonucleotides that detect and modulate gene expression
02/22/2006CN1738914A Methods for using primers that encode one strand of a double-stranded promoter
02/22/2006CN1738911A Solid surface for biomolecule delivery and high-throughput assay
02/22/2006CN1738910A Expression profiling based on histocultures
02/22/2006CN1738896A Composition and method for treating lupus nephritis
02/22/2006CN1738829A New 2',5'-oligoadenylic acid analog
02/22/2006CN1738648A Small interference RNA gene therapy
02/22/2006CN1737144A Composite multiple epitope bivalent nucleic acid vaccine construction for foot-and-mouth disease
02/22/2006CN1737139A Prostate disease related gene and its coding polypeptide and its uses
02/22/2006CN1243018C Blood vessel generating inhibitor
02/22/2006CN1243010C Fast DNA extracting and purifying process with nanoscale particle of aminated silica
02/21/2006US7002057 Thioredoxin H homologs
02/21/2006US7002005 Analytical detection of Staphylococcus aureus
02/21/2006US7002004 Biomolecule and/or cellular arrays on metal surfaces
02/21/2006US7002003 oligonucleotide with optimal nucleotide binding sites for transcription factor; signal trandsducers and activators of transcription (STAT); treating cancer
02/21/2006US7002002 Vaccine against an infectious pathogen from Mycobacterium; 110-12 kd extracellular product proteins
02/21/2006US7002001 Modified human C3 protein for forming said convertase; use in depleting levels of complement pathway protein; preventing transplant rejection
02/21/2006US7001998 Nucleic acids encoding a chimeric glycosyltransferase
02/21/2006US7001997 A metalloprotease having a proteolytic activity; treating various diseases such as diabetic nephropathy, glomerulonephritis, fibrosis, cirrhosis, osteopetrosis and herniated disk; drug screening kits
02/21/2006US7001996 combining aniline monomer, polynucleotide template and redox enzyme, whereby the aniline monomer aligns along the polynucleotide template to form complex and polymerizes to form a polyaniline, thereby forming polynucleotide/polyaniline complex
02/21/2006US7001995 Synthetic human papillomavirus genes
02/21/2006US7001993 site-directed mutagenesis; high protease-inhibitory activity in absence of heparin
02/21/2006US7001891 Biodegradable polycation composition for delivery of an anionic macromolecule
02/21/2006US7001890 Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination
02/21/2006US7001884 polypeptide with selective amino acid substitutions; nontoxic protease inhibitors; bactericides, fungicides, viricides
02/21/2006US7001772 Product and process for transformation of Thraustochytriales microorganisms
02/21/2006US7001763 isolated cDNA, recombinant expression vector, cultured host cell; gene expression; antisense therapy, pharmacogenetics
02/21/2006US7001759 Compositions and methods for delivery of genetic material
02/21/2006US7001757 Protein
02/21/2006US7001754 Methods and compositions for the introduction of molecules into cells
02/21/2006US7001753 59079 and 12599, protein kinase family members and uses therefor
02/21/2006US7001752 Murine and human kinases
02/21/2006US7001751 PyrF gene and the utilization thereof
02/21/2006US7001744 Gene encoding an antigenic determinant of Escherichia coli is connected to a nontoxic cholera toxin A2 and B subunits (CTXA2B) gene of Vibrio cholerae; chimeric protein is useful as oral vaccine against uropathogenic E. coli with mild side effects
02/21/2006US7001726 Amplification of a nucleic acid based signal involving the generation of a repeating structure containing multiple copies of a detectable sequence, and is produced through the concerted action of a polymerase and a separating agent; biochips
02/21/2006US7001725 Assay for the detection of preferential particles
02/21/2006US7001724 Compositions, methods, and kits for isolating nucleic acids using surfactants and proteases
02/21/2006US7001723 Catalytic RNAs with aminoacylation activity
02/21/2006US7001722 Parallel primer extension approach to nucleic acid sequence analysis
02/21/2006US7001721 Nucleic acid sequence identification
02/21/2006US7001720 Cloning of a gene mutation for parkinson's disease
02/21/2006US7001597 Methods for altering fertility
02/21/2006CA2309340C Pyrimidine derivatives for labeled binding partners
02/21/2006CA2091181C Cloning of chicken anaemia dna
02/17/2006CA2573130A1 Isolated fungal promoters and gene transcription terminators and methods of protein and chemical production in a fungus
02/16/2006WO2006017853A2 Mutant interleukin-15-containing compositions and suppression of an immune response
02/16/2006WO2006017196A1 Stable cyanine dye phosphoramidites
02/16/2006WO2006001810A3 Improved inhibitor nucleic acids
02/16/2006WO2005113572A3 Isolated nucleic acid molecules encoding a novel phosphoprotein-darpp-32, encoded protein and uses thereof
02/16/2006WO2005050224A3 Small molecule and peptide arrays and uses thereof
02/16/2006WO2004096992A3 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
02/16/2006WO2004071430A3 RNAi TARGETING OF VIRUSES
02/16/2006WO2004063326A3 Proteorhodopsin mutants with improved optical characteristics
02/16/2006WO2004048451A3 Optical information carrier comprising immobilized proteorhodopsin
02/16/2006WO2003100003A3 Isolated polynucleotides and methods of promoting a morphology in a fungus
02/16/2006WO2003091402A3 N-ACETYLGLUCOSAMINYLTRANSFERASE Vb CODING SEQUENCE, RECOMBINANT CELLS AND METHODS
02/16/2006WO2003050293A3 hGC-1, A GENE ENCODING A MEMBER OF THE OLFACTOMEDIN-RELATED PROTEIN FAMILY
02/16/2006US20060037112 Tomatoes having reduced polygalacturonase activity caused by non-transgenic mutations in the polygalacturonase gene.
02/16/2006US20060037108 Stress tolerance and delayed senescence in plants